Nathan D. Jorgensen

Insider Reports History

Entity
Individual
Location
C/O Vor Biopharma Inc., 100 Cambridgepark Drive, Suite 400, Cambridge, MA
Signature
/s/ Scott MacDonald, as Attorney-in-Fact for Nathan D. Jorgensen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathan D. Jorgensen:

Insider Reports Filed by Nathan D. Jorgensen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYGR Voyager Therapeutics, Inc. Oct 1, 2024 1 $0 4 Oct 2, 2024 Chief Financial Officer
VYGR Voyager Therapeutics, Inc. Jul 8, 2024 1 $0 4 Jul 9, 2024 Chief Financial Officer
VYGR Voyager Therapeutics, Inc. Jul 8, 2024 0 $0 3 Jul 9, 2024 Chief Financial Officer
VOR Vor Biopharma Inc. May 6, 2024 1 -$1.46K 4 May 7, 2024 CHIEF FINANCIAL OFFICER
VOR Vor Biopharma Inc. May 1, 2024 1 -$1.62K 4 May 3, 2024 CHIEF FINANCIAL OFFICER
VOR Vor Biopharma Inc. Mar 1, 2024 1 -$14.3K 4 Mar 5, 2024 CHIEF FINANCIAL OFFICER
VOR Vor Biopharma Inc. Feb 6, 2024 1 -$2.29K 4 Feb 8, 2024 CHIEF FINANCIAL OFFICER
VOR Vor Biopharma Inc. Jan 29, 2024 2 $0 4 Jan 31, 2024 CHIEF FINANCIAL OFFICER
VOR Vor Biopharma Inc. Nov 6, 2023 1 -$1.52K 4 Nov 8, 2023 Chief Financial Officer
VOR Vor Biopharma Inc. Sep 1, 2023 1 -$16.8K 4 Sep 6, 2023 Chief Financial Officer
VOR Vor Biopharma Inc. Aug 7, 2023 1 -$2.23K 4 Aug 9, 2023 Chief Financial Officer
VOR Vor Biopharma Inc. May 8, 2023 1 -$3.45K 4 May 10, 2023 Chief Financial Officer
VOR Vor Biopharma Inc. Mar 1, 2023 1 -$34.8K 4 Mar 2, 2023 Chief Financial Officer
VOR Vor Biopharma Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Chief Financial Officer
VOR Vor Biopharma Inc. Sep 1, 2022 2 $0 4 Sep 6, 2022 Chief Financial Officer
VOR Vor Biopharma Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Financial Officer